"50090-2279-0" National Drug Code (NDC)

Genvoya 30 TABLET in 1 BOTTLE, PLASTIC (50090-2279-0)
(A-S Medication Solutions)

NDC Code50090-2279-0
Package Description30 TABLET in 1 BOTTLE, PLASTIC (50090-2279-0)
Product NDC50090-2279
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameGenvoya
Non-Proprietary NameElvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide
Dosage FormTABLET
UsageORAL
Start Marketing Date20151105
Marketing Category NameNDA
Application NumberNDA207561
ManufacturerA-S Medication Solutions
Substance NameELVITEGRAVIR; COBICISTAT; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
Strength150; 150; 200; 10
Strength Unitmg/1; mg/1; mg/1; mg/1
Pharmacy ClassesHIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/50090-2279-0